Mental Health & Behavioral Research

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Volunteers
Health Professionals

What is the purpose of this trial?

This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.

Trial with
Yale University School of Medicine, YCCI Pilot Project Grant, and National Institute of Mental Health (NIMH)
Ages
21 years - 55 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Study Team

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Benjamin Kelmendi, MD
Assistant Professor of Psychiatry

Sub-Investigators

Last Updated
02/22/2024
Study HIC
#2000020355